Nader Sanai
Clinical trials sponsored by Nader Sanai, explained in plain language.
-
New drug targets Hard-to-Treat brain tumors in early trial
Disease control Recruiting nowThis early-phase trial tests an investigational drug (GSK5764227) that targets a protein called B7-H3 found on some brain tumor cells. It will enroll 15 people with recurrent grade 4 glioma or brain metastases from other cancers. The study first measures how much drug reaches the…
Phase: EARLY_PHASE1 • Sponsor: Nader Sanai • Aim: Disease control
Last updated May 26, 2026 07:20 UTC
-
Could a cancer pill slow aggressive brain tumors?
Disease control Recruiting nowThis study tests whether the drug abemaciclib can help people with a fast-growing type of brain tumor called grade 3 meningioma. Participants will receive either the drug or a placebo after standard radiation therapy. The goal is to see if the drug delays tumor growth and is safe…
Phase: PHASE2 • Sponsor: Nader Sanai • Aim: Disease control
Last updated May 19, 2026 11:47 UTC
-
New hope for glioblastoma: targeted drug enters brain trial
Disease control Recruiting nowThis study is for people with a newly diagnosed, aggressive brain cancer called glioblastoma that has a specific genetic change (MTAP deletion). The trial tests an experimental drug, BGB-58067, designed to target cancer cells while sparing healthy ones. The goal is to see if the …
Phase: EARLY_PHASE1 • Sponsor: Nader Sanai • Aim: Disease control
Last updated May 18, 2026 12:11 UTC